Treatment with Zevalin (ibritumomab tiuxetan), which combines an antibody with a radioactive agent, was found to be safe, reduced tumor burden in most patients, and significantly improved survival without disease ... Read more

Finding the energy to write about the experience of being an immunocompromised person at the time of the coronavirus pandemic is a struggle. I’m exhausted, even though I’ve been ... Read more